The SORT OUT XII dual antiplatelet treatment (DAPT) duration trial, is a clinical randomized controlled superiority and non-inferiority trial to compare whether prasugrel alone versus prasugrel plus aspirin from month 1 to month 12 after percutaneous coronary intervention with and everolimus-eluting stent in patients with acute coronary syndromes (1) is superior regarding clinically relevant bleeding and (2) non-inferior regarding safety (cardiac death, myocardial infarction, definite stent thrombosis, ischemic stroke or clinically driven target lesion revascularization)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
3,150
aspirin 75 mg/day for 1 months plus prasugrel 10 mg/day (5 mg/day) for 1 year, followed by lifelong aspirin 75 mg/day after 1 year
aspirin 75 mg/day lifelong plus prasugrel 10 mg/day (5 mg/day) for 1 year
Aalborg University Hospital
Aalborg, Denmark
NOT_YET_RECRUITINGAarhus University Hospital
Aarhus, Denmark
RECRUITINGOdense University Hospital
Odense, Denmark
RECRUITINGNumber of patients with clinically relevant bleeding (Effectiveness)
Clinically relevant bleeding is defined a "Bleeding Academic Research Consortium" (BARC) where BARC group 2, 3 and 5 are registered
Time frame: 1 year
Number of patients with a composite major adverse cardiovascular or cerebrovascular events (Safety)
Major adverse cardiovascular or cerebrovascular events (MACCE) is defined as a composite of cardiac death, myocardial infarction, definite stent thrombosis, ischemic stroke or clinically driven target lesion revascularization)
Time frame: 1 year
Number of patients with clinically relevant bleeding
Clinically relevant bleeding is defined a "Bleeding Academic Research Consortium" (BARC) 2, 3 and 5, where BARC group 2, 3 and 5 are registered
Time frame: 1 year
Number of patients with all-cause death
All-cause death is defined as any death
Time frame: 1 year
Number of patients with cardiac death
Cardiac death is defined as death resulting from cardiovascular causes: death caused by acute myocardial infarction, death caused by sudden cardiac, including unwitnessed, death, death resulting from heart failure, death caused by cardiovascular procedures. Undetermined cause of death is defined as a death not attributable to any other category because of the absence of any relevant source documents. Such deaths will be classified as cardiovascular for end point determination
Time frame: 1 year
Number of patients with myocardial infarction
Myocardial infarction diagnosis follows "The Joint ESC/ACCF/AHA/WHF Task Force on "Third Universal Definition of acute myocardial infarction",which has been adapted by Academy Research Consortium. Acute myocardial infarction not related to other than index lesion is defined as any acute myocardial infarction that is not clearly attributable to a non-target vessel
Time frame: 1 year
Number of patients with definite stent thrombosis
Definite stent thrombosis is defined as: Angiographic confirmation of stent thrombosis. The presence of a thrombus that originates in the stent or in the segment 5 mm proximal or distal to the stent or in a side branch originating from the stented segment and the presence of at least one of the following criteria: Acute onset of ischemic symptoms at rest New electrocardiographic changes suggestive of acute ischemia Typical rise and fall in cardiac biomarkers (refer to definition of spontaneous myocardial infarction) Or Pathological confirmation of stent thrombosis
Time frame: 1 year
Number of patients with target lesion revascularization
Target lesion revascularization is defined as a repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion. The target lesion is defined as the treated segment including the 5-mm margin proximal and distal to the stent
Time frame: 1 year
Number of patients with stroke
Ischemic stroke is defined from the Neurologic Academic Research Consortium (Neuro-ARC): Classification on the basis of symptoms and evidence of CNS injury, including overt (acutely symptomatic) CNS injury (Type 1), covert (acutely asymptomatic) CNS injury (Type 2), and neurological dysfunction (acutely symptomatic) without CNS injury (Type 3)
Time frame: 1 year
Health-related quality of life
Health-related quality of life (HRQoL) will be assessed by the health state classifier EQ-5D
Time frame: 1 month and 1 year
Angina status
Angina status is based on the Canadian Cardiovascular Society classification system (SaQ)
Time frame: 1 month and 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.